Greenleaf Pharmaceuticals (02186.HK) has completed the issuance of $180 million US Dollars with a 5.25% interest rate due in 2031 convertible bonds.

Wisdom Financial APP News, Leaf Pharm (02186.HK) announced that all the prerequisites of the subscription agreement for the issuance of bonds have been met, and the total principal amount of the subscribed and issued bonds is $180 million, which was completed on June 10, 2026. These bonds were listed on the Vienna Stock Exchange on June 10, 2026.